Latest stories on MBRX
Moleculin Highlights Strong Market Interest in Annamycin AML Therapy
TipRanks58 · neutralproduct/pr
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
TipRanks58 · neutralproduct/pr
Moleculin Biotech Releases Updated Investor Information Presentation
TipRanks53 · neutralproduct/pr
Moleculin Highlights Annamycin Cardiac Safety Data at ASCO
TipRanks58 · neutralproduct/pr
Moleculin Biotech GAAP EPS of -$3.54 misses by $2.08
Seeking Alpha33 · bearishearnings